CIK: 0001792206 · Show all filings
Period: Q4 2023 (← Previous) (Next →)
Filing Date: Feb 13, 2024
Total Value ($000): $73,392 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| HIMS | Hims & Hers Health, Inc. | 3,833,381 | $34,117 | 46.5% | $8.41 | -12.1% | COM CL A | 433000106 |
| — | Theseus Pharmaceuticals, Inc. | 4,108,796 | $16,641 | 22.7% | $10.73 | — | COM | 88369M101 |
| IRON | Disc Medicine, Inc. | 243,513 | $14,065 | 19.2% | $49.79 | +2.8% | COM | 254604101 |
| — | Kinnate Biopharma Inc. | 3,525,957 | $8,357 | 11.4% | $13.15 | — | COM | 49705R105 |
| — | 23andMe Holding Co. | 232,200 | $212 | 0.3% | $0.91 | — | CLASS A COM | 90138Q108 |